BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
1555051
Number of visits today
222
Number of downloads
1205160
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Del Genio V, Bellavita R, Falanga A, Hervé-Aubert K, Chourpa I, Galdiero S. Peptides to Overcome the Limitations of Current Anticancer and Antimicrobial Nanotherapies. Pharmaceutics 2022;14:1235. [PMID: 35745807 DOI: 10.3390/pharmaceutics14061235] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Bellavita R, Braccia S, Galdiero S, Falanga A. Glycosylation and Lipidation Strategies: Approaches for Improving Antimicrobial Peptide Efficacy. Pharmaceuticals 2023;16:439. [DOI: 10.3390/ph16030439] [Reference Citation Analysis]
2 Bellavita R, Leone L, Maione A, Falcigno L, D'Auria G, Merlino F, Grieco P, Nastri F, Galdiero E, Lombardi A, Galdiero S, Falanga A. Synthesis of temporin L hydroxamate-based peptides and evaluation of their coordination properties with iron(III ). Dalton Trans 2023. [PMID: 36744636 DOI: 10.1039/d2dt04099a] [Reference Citation Analysis]
3 Bellavita R, Maione A, Braccia S, Sinoca M, Galdiero S, Galdiero E, Falanga A. Myxinidin-Derived Peptide against Biofilms Caused by Cystic Fibrosis Emerging Pathogens. Int J Mol Sci 2023;24. [PMID: 36834512 DOI: 10.3390/ijms24043092] [Reference Citation Analysis]
4 Del Genio V, Falanga A, Allard-Vannier E, Hervé-Aubert K, Leone M, Bellavita R, Uzbekov R, Chourpa I, Galdiero S. Design and Validation of Nanofibers Made of Self-Assembled Peptides to Become Multifunctional Stimuli-Sensitive Nanovectors of Anticancer Drug Doxorubicin. Pharmaceutics 2022;14:1544. [PMID: 35893800 DOI: 10.3390/pharmaceutics14081544] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345